5,68 €
1,79 % gestern
L&S, 23. Mai, 22:54 Uhr
ISIN
CA92663R1055
Symbol
VMD
Berichte

Viemed Healthcare Inc Aktie News

Neutral
Seeking Alpha
14 Tage alt
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q1 2025 Earnings Conference Call May 8, 2025 11:00 AM ET Company Participants Casey Hoyt – Chief Executive Officer Trae Fitzgerald – Chief Financial Officer Todd Zehnder – Chief Operating Officer Conference Call Participants Brooks O'Neil – Lake Street Capital Ryan Langston – TD Cowen Andrew Rem – Odinson Partners Operator Good day, ladies and gentlemen, an...
Neutral
GlobeNewsWire
16 Tage alt
LAFAYETTE, La., May 07, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2025, and updated guidance for the full year ending December 31, 2025.
Neutral
GlobeNewsWire
18 Tage alt
LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, announced that it has entered into a definitive agreement to acquire Illinois-based Lehan's Medical Equipment (“Lehan”), a healthcare company offering home medical e...
Neutral
GlobeNewsWire
etwa ein Monat alt
LAFAYETTE, La., April 22, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, today announced that it will host its First Quarter 2025 Earnings Conference Call on Thursday, May 8, 2025, at 11:00 a.m. EDT.
Positiv
Seeking Alpha
etwa ein Monat alt
Viemed Healthcare's stock has declined recently, but bullish EPS revisions and strong growth projections make it an attractive buy near its long-term bottom. The company projects significant revenue and EBITDA growth for 2025, with EPS expected to rise by 42.86% in 2025 and 52.5% in 2026. Viemed's valuation remains attractive, with positive cash flow and rising equity, despite the stock's recen...
Neutral
Seeking Alpha
2 Monate alt
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q4 2024 Earnings Conference Call March 11, 2025 11:00 AM ET Company Participants Todd Zehnder - COO Trae Fitzgerald - CFO Casey Hoyt - CEO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Andrew Rem - Odinson Partners Operator Greetings, and welcome to the Viemed Healthcare Year-End 2024 Earnings Call. At this time all participants a...
Neutral
GlobeNewsWire
2 Monate alt
LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months and year ended December 31, 2024, and issued its guidance for the full year ending December 31, 2025.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen